November was an exciting month for the vascular medicine community, with back-to-back conferences spotlighting advancements in the field. At VIVA 2024 and the VEITH Symposium, the focus ranged from innovative devices to the emerging role of AI in vascular care. These two events showcased the state of vascular innovation while revealing the gaps and opportunities still to be addressed.
Here are our top takeaways from both conferences:
The role of AI in vascular care is still in its early stages, with pockets of success seen in areas like pulmonary embolism (PE) management and pulmonary embolism response team (PERT) workflows. These AI-driven advancements demonstrate how technology can:
AI’s impact on vascular care extends beyond acute PE scenarios to conditions like aortic pathologies, deep vein thrombosis (DVT) and eventually peripheral artery disease (PAD).
However, adoption varies across specialties:
The journey for AI adoption in vascular surgery may take time, given the specialty’s traditionally conservative approach to new technologies. Still, these early successes by early adopters, signal that AI is paving the way for greater efficiency and better outcomes in both urgent and elective case scenarios.
At both VIVA and VEITH, VTE management stood out as a critical area of focus. Chronic conditions like DVT are shifting the conversation beyond acute interventions to encompass long-term care. Key themes included:
These discussions emphasized the importance of integrating AI into care pathways, not only for acute emergencies but also for chronic disease management.
As mechanical thrombectomy gains traction, procedural volumes are climbing—and so is the demand for tools to support care teams. Clinicians are increasingly seeking solutions that offer:
These tools are pivotal for ensuring that expanding procedural volumes translate into better patient outcomes, not provider burnout.
Conversations at both conferences emphasized the industry’s need for tailored solutions that fit seamlessly into existing practices. Clinicians expressed enthusiasm for:
It’s clear that vascular professionals are looking for more than technology—they want solutions that truly help improve their practice.
A consistent theme at both conferences was the importance of collaboration—not only between specialties but between clinicians, researchers and technology providers. AI-driven solutions have the power to unite different areas of vascular care, fostering more cohesive and effective treatment pathways.
The conversations at VIVA 2024 and the VEITH Symposium highlighted a dynamic period for vascular care, with AI offering exciting possibilities for innovation. While its adoption is still in its fancy, especially among vascular surgeons, early successes in areas like PE and VTE management point to a promising future.
At Aidoc, we’re committed to helping clinicians bridge the gaps in vascular care, from identifying high-risk patients to streamlining care delivery. Together, we can move the field forward—one innovation at a time.
Aidoc experts, customers and industry leaders share the latest in AI benefits and adoption.
Explore how clinical AI can transform your health system with insights rooted in real-world experiences.
Learn how to go beyond the algorithm to develop a scalable AI strategy and implementation plan.
Explore how Aidoc can help increase hospital efficiency, improve outcomes and demonstrate ROI.
